Published in J Urol on November 14, 2007
Shock wave lithotripsy: advances in technology and technique. Nat Rev Urol (2009) 1.67
Effect of firing rate on the performance of shock wave lithotriptors. BJU Int (2008) 1.35
Extracorporeal shock wave lithotripsy at 60 shock waves/min reduces renal injury in a porcine model. BJU Int (2009) 1.11
Treatment protocols to reduce renal injury during shock wave lithotripsy. Curr Opin Urol (2009) 1.05
Comparison between two shock wave regimens using frequencies of 60 and 90 impulses per minute for urinary stones. Clinics (Sao Paulo) (2010) 1.02
Optimising an escalating shockwave amplitude treatment strategy to protect the kidney from injury during shockwave lithotripsy. BJU Int (2012) 0.91
Evaluation of shock wave lithotripsy injury in the pig using a narrow focal zone lithotriptor. BJU Int (2012) 0.90
Optimizing shock wave lithotripsy: a comprehensive review. Rev Urol (2013) 0.86
Surgical management of stones: new technology. Adv Chronic Kidney Dis (2009) 0.85
Clinical significance of residual fragments in 2015: impact, detection, and how to avoid them. World J Urol (2015) 0.85
Shock wave lithotripsy: the new phoenix? World J Urol (2014) 0.84
Controlled cavitation to augment SWL stone comminution: mechanistic insights in vitro. IEEE Trans Ultrason Ferroelectr Freq Control (2013) 0.84
The management of ureteric stones. Ann R Coll Surg Engl (2010) 0.81
Extracorporal shock wave lithotripsy in the management of stones in children with oxalosis--still the first choice? Pediatr Nephrol (2013) 0.81
Aspects on how extracorporeal shockwave lithotripsy should be carried out in order to be maximally effective. Urol Res (2012) 0.78
Acoustic bubble removal to enhance SWL efficacy at high shock rate: an in vitro study. J Endourol (2013) 0.78
Re: The effect of shock wave rate on the outcome of shock wave lithotripsy: a meta-analysis. J Urol (2008) 0.75
Best of the AUA Annual Meeting: Highlights From the 2010 American Urological Association Meeting, May 29-June 3, 2010, San Francisco, CA. Rev Urol (2010) 0.75
Removal of residual cavitation nuclei to enhance histotripsy erosion of model urinary stones. IEEE Trans Ultrason Ferroelectr Freq Control (2015) 0.75
Kidney stones. BMJ Clin Evid (2011) 0.75
Strategies to optimize shock wave lithotripsy outcome: Patient selection and treatment parameters. World J Nephrol (2015) 0.75
Using the Promise of Sonodynamic Therapy in the Clinical Setting against Disseminated Cancers. Chemother Res Pract (2015) 0.75
Does the rate of shock wave delivery affect outcomes in patients receiving shock wave lithotripsy for urinary calculi? Nat Clin Pract Urol (2008) 0.75
Generation and Quantitative Analysis of Pulsed Low Frequency Ultrasound to Determine the Sonic Sensitivity of Untreated and Treated Neoplastic Cells. J Vis Exp (2015) 0.75
How to improve results with extracorporeal shock wave lithotripsy. Ther Adv Urol (2009) 0.75
Evaluation of the optimal frequency of and pretreatment with shock waves in patients with renal stones. Korean J Urol (2011) 0.75
Associations between interventions for urolithiasis and urinary tract cancer among patients in Taiwan: The effect of early intervention. Medicine (Baltimore) (2016) 0.75
Kidney stones. BMJ Clin Evid (2009) 0.75
Re: comparison between two shock wave regimens using frequencies of 60 and 90 impulses per minute for urinary stones. Clinics (Sao Paulo) (2011) 0.75
Comparison of treatment outcomes according to output voltage during shockwave lithotripsy for ureteral calculi: a prospective randomized multicenter study. World J Urol (2014) 0.75
Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability. J Natl Cancer Inst (2006) 6.02
Active surveillance program for prostate cancer: an update of the Johns Hopkins experience. J Clin Oncol (2011) 5.27
Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst (2007) 4.85
Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans. J Natl Cancer Inst (2007) 4.24
Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol (2011) 3.36
Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12. Nat Genet (2008) 3.14
Delayed versus immediate surgical intervention and prostate cancer outcome. J Natl Cancer Inst (2006) 2.96
An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011. BJU Int (2012) 2.77
The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up. BJU Int (2011) 2.68
Retracted EPCA-2: a highly specific serum marker for prostate cancer. Urology (2007) 2.67
Pathological outcomes in men with low risk and very low risk prostate cancer: implications on the practice of active surveillance. J Urol (2013) 2.66
Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. J Clin Invest (2005) 2.38
Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy? Correlation with radical prostatectomy findings. Am J Surg Pathol (2011) 2.20
Urinary outcomes are significantly affected by nerve sparing quality during radical prostatectomy. Urology (2013) 2.11
National Institutes of Health state-of-the-science conference statement: prevention of fecal and urinary incontinence in adults. Ann Intern Med (2008) 2.10
The association of increasing body mass index and kidney stone disease. J Urol (2009) 1.94
Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol (2004) 1.85
Gleason score 6 adenocarcinoma: should it be labeled as cancer? J Clin Oncol (2012) 1.78
Sex prevalence of pediatric kidney stone disease in the United States: an epidemiologic investigation. Urology (2009) 1.74
Association of prostate cancer risk variants with clinicopathologic characteristics of the disease. Clin Cancer Res (2008) 1.74
Validity of administrative coding in identifying patients with upper urinary tract calculi. J Urol (2010) 1.72
A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall's plaque. BJU Int (2008) 1.72
Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy. J Clin Oncol (2005) 1.69
Laparoscopic live donor nephrectomy: trends in donor and recipient morbidity following 381 consecutive cases. Ann Surg (2004) 1.63
Prostate specific antigen testing among the elderly--when to stop? J Urol (2009) 1.62
Causes of death after radical prostatectomy at a large tertiary center. J Urol (2012) 1.61
Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success. AJR Am J Roentgenol (2004) 1.56
The effect of gastric banding on kidney stone disease. Urology (2009) 1.56
Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations. Prostate (2008) 1.53
Medical comorbidities associated with pediatric kidney stone disease. Urology (2010) 1.50
Techniques for fluoroscopic percutaneous renal access. J Urol (2007) 1.50
What are the outcomes of radical prostatectomy for high-risk prostate cancer? Urology (2009) 1.49
Differentiation of kidney stones using dual-energy CT with and without a tin filter. AJR Am J Roentgenol (2012) 1.49
Risk stratification of men choosing surveillance for low risk prostate cancer. J Urol (2010) 1.47
Pathological and oncologic outcomes for men with positive lymph nodes at radical prostatectomy: The Johns Hopkins Hospital 30-year experience. Prostate (2013) 1.46
Effect of treatment with 5-α reductase inhibitors on progression in monitored men with favourable-risk prostate cancer. BJU Int (2012) 1.44
Laparoscopic partial nephrectomy: effect of warm ischemia on serum creatinine. J Urol (2004) 1.44
Trends in renal surgery: robotic technology is associated with increased use of partial nephrectomy. J Urol (2012) 1.42
Modeling grade progression in an active surveillance study. Stat Med (2013) 1.41
Treatment decision-making for localized prostate cancer: what younger men choose and why. Prostate (2011) 1.30
Natural history of pathologically organ-confined (pT2), Gleason score 6 or less, prostate cancer after radical prostatectomy. Urology (2008) 1.27
Prostate cancer mortality following active surveillance versus immediate radical prostatectomy. Clin Cancer Res (2012) 1.25
Prostate specific antigen progression in men with lymph node metastases following radical prostatectomy: results of long-term followup. J Urol (2004) 1.24
The impact of anatomical radical retropubic prostatectomy on cancer control: the 30-year anniversary. J Urol (2012) 1.24
Impact of renal artery multiplicity on outcomes of renal donors and recipients in laparoscopic donor nephrectomy. Urology (2003) 1.15
Impact of surgical margin status on prostate-cancer-specific mortality. BJU Int (2012) 1.13
How do we manage infected, obstructed hydronephrosis? Eur Urol (2012) 1.10
The natural history of men treated with deferred androgen deprivation therapy in whom metastatic prostate cancer developed following radical prostatectomy. J Urol (2007) 1.10
Acute effects of percutaneous tract dilation on renal function and structure. J Endourol (2006) 1.09
Ureteroscopic management of renal calculi in anomalous kidneys. Urology (2005) 1.08
In vitro assessment of a novel dual probe ultrasonic intracorporeal lithotriptor. J Urol (2007) 1.07
Nightly vs on-demand sildenafil for penile rehabilitation after minimally invasive nerve-sparing radical prostatectomy: results of a randomized double-blind trial with placebo. BJU Int (2013) 1.06
Impact of patient age on biochemical recurrence rates following radical prostatectomy. J Urol (2007) 1.06
Trends in imaging use during the emergency department evaluation of flank pain. J Urol (2011) 1.05
Acceptability of diagnostic tests for breast cancer. Breast Cancer Res Treat (2003) 1.05
Classification and trends of perioperative morbidities following laparoscopic radical prostatectomy. J Urol (2005) 1.05
Holmium laser enucleation of the prostate for men with urinary retention. J Urol (2005) 1.04
Renal functional effects of multiple-tract percutaneous access. J Endourol (2009) 1.04
The safety of ureteroscopy during pregnancy: a systematic review and meta-analysis. J Urol (2008) 1.02
Allogeneic versus autologous blood transfusion and survival after radical prostatectomy. Transfusion (2014) 1.00
The effect of restrictive bariatric surgery on urinary stone risk factors. Urology (2010) 0.99
Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy. J Urol (2007) 0.98
Holmium laser enucleation of the prostate: efficiency gained by experience and operative technique. J Urol (2010) 0.98
Drug-induced urinary calculi. Rev Urol (2003) 0.97
Salvage or adjuvant radiation therapy: counseling patients on the benefits. J Natl Compr Canc Netw (2010) 0.97
Nephrolithiasis: what surgeons need to know. AJR Am J Roentgenol (2011) 0.96
Management of stone disease in pregnancy. Curr Opin Urol (2010) 0.95
Calcium oxalate calculi found attached to the renal papilla: Preliminary evidence for early mechanisms in stone formation. J Endourol (2006) 0.95
The presence of horseshoe kidney does not affect the outcome of percutaneous nephrolithotomy. J Endourol (2008) 0.95
The impact of obesity on urinary tract infection risk. Urology (2011) 0.94
A critical analysis of the interpretation of biochemical failure in surgically treated patients using the American Society for Therapeutic Radiation and Oncology criteria. J Urol (2002) 0.93
Impact of body mass index on biochemical recurrence rates after radical prostatectomy: an analysis utilizing propensity score matching. Urology (2008) 0.92
Relationship between primary Gleason pattern on needle biopsy and clinicopathologic outcomes among men with Gleason score 7 adenocarcinoma of the prostate. Urology (2006) 0.92
In vitro fertilization and the cloacal-bladder exstrophy-epispadias complex: is there an association? J Urol (2003) 0.92
Incidence and risk factors for inguinal and incisional hernia after laparoscopic radical prostatectomy. Urology (2011) 0.92
Impact of hospital volume on perioperative outcomes and costs of radical cystectomy: analysis of the Maryland Health Services Cost Review Commission database. Can J Urol (2014) 0.91
3-year actuarial biochemical recurrence-free survival following laparoscopic radical prostatectomy: experience from a tertiary referral center in the United States. J Urol (2008) 0.91
Multicenter analysis of postoperative CT findings after percutaneous nephrolithotomy: defining complication rates. Urology (2011) 0.90
Serum biomarker measurements of endothelial function and oxidative stress after daily dosing of sildenafil in type 2 diabetic men with erectile dysfunction. J Urol (2008) 0.90
Results of the 5 region prostate biopsy method: the repeat biopsy population. J Urol (2002) 0.90
Active surveillance for low-risk prostate cancer. Crit Rev Oncol Hematol (2012) 0.89
Kidney stones and pregnancy. Adv Chronic Kidney Dis (2013) 0.89
Biobanking of derivatives from radical retropubic and robot-assisted laparoscopic prostatectomy tissues as part of the prostate cancer biorepository network. Prostate (2013) 0.89
Is pelvic osteotomy associated with lower risk of pelvic organ prolapse in postpubertal females with classic bladder exstrophy? J Urol (2012) 0.89
The effect of ureteral stent placement on post-ureteroscopy complications: a meta-analysis. Urology (2008) 0.88
Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomy. J Urol (2009) 0.88
Stones: can the Guy's stone score predict PNL outcomes? Nat Rev Urol (2011) 0.86
Renal functional effects of simultaneous bilateral single-tract percutaneous access in pigs. BJU Int (2009) 0.85
Complications of renal cryoablation: a single center experience. J Urol (2010) 0.85
Transsplenic percutaneous nephrolithotomy. J Endourol (2008) 0.85